Oruka Therapeutics (NASDAQ: ORKA) files $1B shelf to sell equity, warrants

Oruka Therapeutics, Inc. filed a shelf registration to offer up to $1,000,000,000 of common stock, preferred stock, depositary shares and warrants, to be sold from time to time in one or more offerings. The prospectus states securities may be sold directly, through agents or underwriters, on a continuous or delayed basis, with specific terms provided in prospectus supplements. The company’s common stock trades on the Nasdaq Global Market under the symbol ORKA, with a reported last sale price of $50.43 per share on April 1, 2026. The prospectus incorporates by reference the company’s periodic reports and risk factors, and notes that use of proceeds, pricing, and underwriting terms will be set forth in future prospectus supplements.

https://www.stocktitan.net/sec-filings/ORKA/s-3-oruka-therapeutics-inc-shelf-registration-statement-d6d5850b7126.html